Join to View Full Profile
9500 Euclid Avenue Desk U10Cleveland ClinicCleveland, OH 44195
Phone+1 216-444-2200
Fax+1 216-636-2989
Dr. Abboud is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationFellowship, Neuroimmunology & Multiple Sclerosis, 2015 - 2016
Johns Hopkins UniversitySpecial training, Transverse myelitis and NMO, 2014 - 2015- Cleveland Clinic FoundationResidency, Neurology, 2011 - 2015
- Cleveland Clinic FoundationFellowship, Neuromuscular Medicine (Neurology), 2009 - 2011
University of Alexandria Faculty of MedicineClass of 2002
Certifications & Licensure
OH State Medical License 2009 - 2025
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Travel Grant ACTRIMS/ECTRIMS, 2014, 2016-2017
- International Movement Disorder Congress Travel Award MDS, 2012, 2014, 2017
- Finalist, young investigator award ACTRIMS, 2016
- Join now to see all
Clinical Trials
- Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase Start of enrollment: 2006 May 01
- N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders Start of enrollment: 2015 Apr 01
Publications & Presentations
PubMed
- The Clinical Trial Landscape in Autoimmune Encephalitis: Challenges and Opportunities.Hesham Abboud, Stacey L Clardy, Divyanshu Dubey, Jonathan Wickel, Gregory Scott Day
Neurology. 2025-04-22 - Movement disorders in relapsing and progressive MS: A comprehensive prospective evaluation of a large real-life cohort.Hannah Kelly, Rongyi Sun, Mohamed Elkasaby, Alexander Wang, Hesham Abboud
Journal of the Neurological Sciences. 2025-03-22 - Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series.Hesham Abboud, Brian Steingo, Diana Vargas, Julie Patel, Nancy Nealon
Journal of Neuroimmunology. 2025-03-16
Press Mentions
Study Suggests No Overall Increased Risk of MS Relapse After COVID BoostersAugust 15th, 2024- Consortium of Multiple Sclerosis Centers (CMSC) & NeurologyLive® Announce “The Ever Changing Face of MS” Webinar SeriesApril 28th, 2021
- Local School Shows Support for Boy Who Has Been in Medically Induced Coma for 70 DaysSeptember 23rd, 2020
- Join now to see all
Grant Support
- Clinical MS fellowshipNational Multiple Sclerosis Society2015–2016
Committees
- Reviewer, Multiple Sclerosis Journal 2018 - Present
- Reviewer, Parkinsonism and Related Disorders 2018 - Present
- Reviewer, Multiple Sclerosis Journal: Experimental, Translational and Clinical 2017 - Present
- Reviewer, International Journal of MS Care 2016 - Present
- Reviewer, The American Journal of Psychiatery 2016 - Present
- Reviewer, Journal of the Neurological Sciences 2015 - Present
- Reviewer, Neurology Journal 2014 - Present
Professional Memberships
- Member
- International Movement Disorders SocietyMember
- NMO International Clinical ConsortiumMember
- Autoimmune Encephalitis AllianceMember
- Consortium of Multiple Sclerosis CentersMember
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
